Position in ALKS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$387,917
-$977,863 QoQ
Shares Held
7,403
-80.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#268
of 423 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CenterBook Partners LP holds $8,224,392 across 8 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
33,061 | $2,375,763 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
|
280,565 | $2,222,074 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
19,434 | $1,242,804 | |
| 4 | EOLS |
Evolus, Inc.
|
91,741 | $636,682 | |
| 5 | LQDA |
Liquidia Corp
|
7,706 | $614,399 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
16,065 | $504,441 | |
| 7 | ALKS |
Alkermes plc.
This page
|
7,403 | $387,917 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
5,857 | $240,312 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $387,917 | 7,403 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,365,780 | 38,625 | Shares | Sole | 2026-05-05 | |
| 2025-09-30 | $837,840 | 27,928 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $610,794 | 21,349 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||